Case Studies

Mapping a rival’s brand ecosystem to guide market strategy

Posted by | Fuld & Company

Introduction

​A global leader in hygiene services engaged Fuld to deliver competitive intelligence on a key rival and its portfolio of sub-brands. The client needed a clearer view of how this competitor was executing its US strategy to support business growth and defend market share. ​ 

Objective 

​​The company wanted insight into a competitor’s sales models, pricing, customer retention, and use of sub-brands. The goal was to create a fact base to guide market positioning, account management, and future growth planning. 

​Solution 

​Fuld analyzed how the rival’s sub-brands operated, each with its own approach and a degree of independence. By connecting these elements, we built a view of how the brand ecosystem functioned, including customer retention, market coverage, and account handling, and translated those insights into strategic options for the client. 

Research design 

​Fuld’s approach combined qualitative and secondary research methods to build a rounded view of the competitor’s operations and market strategy including: 

  • ​Expert interviews with recent former operators and leaders 
  • ​Targeted secondary research drawing on industry sources and digital signals 

​​Results and impact 

​The research provided the company with a consolidated view of its competitor’s strategy and operating model. Findings highlighted how the rival balanced local execution with national account strategies and leveraged its brand portfolio to maintain customer loyalty and extend reach. These insights offered a stronger foundation for growth and defense planning, shaping actions on market positioning, pricing, and account management. 

Tags: , , ,

Related Resources

Read More

​Turning coffee into a growth driver for a global food services leader

​Introduction  ​A global leader in food services and facilities management serving nearly 100 million consumers daily across multiple sectors, faced […]

Read More

​How Smart Licensing of a Clinical-Stage Degrader Strengthened Oncology Pipeline

​Objective  ​A US-based biopharma company aimed to expand its immuno-oncology pipeline by in-licensing immuno-oncology strategies through a differentiated clinical-stage targeted […]

Read More

How Deeper Intelligence Shifted a SaaS Leader’s Competitive Strategy

A leading US SaaS company needed to understand the potential threat of a successful new start-up. From publicly available market […]

Subscribe to our mailing list for our latest updates:

Subscribe Now